Patient P-02178
Synthetic patientMETA-24 · Day 168 · 25–34 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
25%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity+7
- Treatment adherence-5
- GI instability+4
- Nutritional resilience+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable83 min
worsening · -7.4 vs previous 14 d
Sleep duration
Wearable6.4 h
worsening · -0.4 vs previous 14 d
Energy level
Daily log6.7/10
worsening · -0.6 vs previous 14 d
Steps
Wearable9,677
worsening · -474 vs previous 14 d
GI burden
Companion15.1/100
worsening · +5.4 vs previous 14 d
Adherence
Companion92.6 %
stable · +1.3 vs previous 14 d
Sleep quality
Wearable55.1/100
worsening · -7.6 vs previous 14 d
Glucose, CGM daily mean
CGM122 mg/dL
stable · -0.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 92 from the failing basin, 6 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -6.6 next day on high-intake days · n 19
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6.6supporter · 95%
- Simple carbohydrates+2.3no signal · 44%
- Dietary fat load+1.6no signal · 26%
- Caffeine-1.6no signal · 26%
- Alcohol-1.1no signal · 17%
- Histamine load+1no signal · 19%
- Ultra-processed food-0.3no signal · 15%
- Insoluble fibre+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.5 · butyrate capacity 67/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 65 ms
- Sleep
- 6.4 h
- Steps
- 8,301
- Resting HR
- 65 bpm
Daily log: GI score 15, nutritional resilience 66, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.